Resumen
Peroxisome proliferator-activated receptors (PPARs) have emerged as key regulators of physiological and immunological processes. Recently, one of their members PPARβ/δ has been identified as major player in the maintenance of bone homeostasis, by promoting Wnt signalling activity in osteoblast and mesenchymal stem cells (MSC). PPARβ/δ not only controls the fate of MSC but also regulates their immunosuppressive properties by directly modulating their NF-κB activity. In this review, we discuss how the regulation of PPARβ/δ provides an innovative strategy for an optimisation of MSC-based therapy.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 55-58 |
Número de páginas | 4 |
Publicación | Biochimie |
Volumen | 136 |
DOI | |
Estado | Publicada - 1 may. 2017 |
Nota bibliográfica
Publisher Copyright:© 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM)
Palabras clave
- Animals
- Humans
- Immune tolerance
- mesenchymal stromal cells
- Osteogenesis
- PPAR gamma
- PPAR-beta